Tran A, Rochwerg B. In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survival. Ann Intern Med 2022 Oct 4. doi: 10.7326/J22-0074.
PMID: 36191322